Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DragonFly-T System for Tricuspid Regurgitation
NCT05556460Recruiting
- Sponsor
- Valgen Medtech
- Start
- Sep 2024
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in tricuspid regurgitation (2 arms), sponsored by Valgen Medtech. Primary endpoint: Hierarchical Composite of All-cause Death or Tricuspid Valve Intervention, Heart Failure Hospitalizations, and KCCQ Improvement at 12 months. Started Sep 2024; status: recruiting.
02
Conditions
tricuspid regurgitation
Beyond the preview
Go deeper on NCT05556460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05556460.